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Human Genome Epidemiology is edited by three well-
recognized experts in genetic epidemiology, and their expe-
rience shows in the information and organization of this
text. While they do not define their intended audience, the
material focuses on the complexities of epidemiologic
study and design in population-based genomics.
Readability characterizes all the chapters, and the con-
cepts will be accessible to anyone with a firm grounding in
epidemiologic principles. Hence, the book will be useful for
both the graduate student and the experienced practition-
er who wish to learn more about this field.
The book contains four parts. Part One is devoted to the
basics of common definitions, molecular biology, and the
laboratory testing that drove the Human Genome Project
and continue to be central in genomic research. Definitions
include distinguishing genetics (the study of single genes
and their effects) from genomics (the study of both single
genes and the functions and interactions of all genes in the
genome). An example of the editors’ thorough attention to
detail is a chapter on the ethics related to genomic studies.
Part Two is the most technical aspect of the text and
examines the application of standard epidemiologic
research techniques in human genomics. These chapters
discuss additional research methods unique to human
genome epidemiology and provide comprehensive descrip-
tions of the strengths and drawbacks of each research
technique. The final chapter in this section provides a
checklist for designing and reporting genomic epidemio-
logic studies. At this point, the average epidemiologist
should have the information necessary for assessing exist-
ing studies and perhaps designing credible original studies
as well.
How useful will the results of these studies prove to
practical disease prevention? Part Three explores three
types of validity for human genetic tests. Analytic validity
is the sensitivity, specificity, and predictive value of a lab-
oratory test for genotype. Clinical validity refers to the
same values with respect to phenotype; that is, is a given
test a good measure of gene–disease association?  Last,
clinical utility refers to whether such tests provide infor-
mation that can change disease outcomes. The remainder
of this section discusses the application of these concepts
to clinical medicine, pharmacology, and randomized clini-
cal trials and offers guidelines for assessing these values in
different settings.
Part Three leaves the reader with a sense that while
genetic testing may be useful in clinical contexts or among
select high-risk populations, there is little evidence to sup-
port the use of most genetic tests in mass population test-
ing. Part Four reinforces this concept by providing 12 case
studies on using human genome epidemiology to improve
health. In one example after another, reasonable evidence
often supports an association between a health outcome
and a gene, a gene–gene interaction, or a gene–environ-
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ment interaction. But never does the evidence suggest that
general population testing would be an appropriate public
health response.
One might infer that this text indicates a limited role for
human genomic epidemiology in current public health
practice. However, the book does offer important points for
practical epidemiology. This is a rapidly growing field, and
research epidemiologists can play an essential role in
designing and conducting research. In fact, we may learn
tomorrow of genetic tests with immediate general popula-
tion applications. When such reports do become available,
it will be essential for epidemiologists to quickly grasp the
strengths and limitations of the interpreted studies. As
genetic testing becomes a high-profile public discussion,
epidemiologists will need to provide policy makers with a
clear understanding of how to separate the wheat from the
chaff in determining public health actions. The editors
note that the results of genomic epidemiologic studies can
be explored by other disciplines: policy (to decide value
added), communication (to explain risk information), eco-
nomics (to examine cost effectiveness), and outcomes
research (to measure impact). For the most part, these
aspects are not discussed in this text, but public health
professionals will need to address them all to use human
genomic epidemiology effectively in practice.
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